Similar articles

• Editorial comment on: the value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer.

  Pycha A. Pycha A. Eur Urol. 2008 Aug;54(2):408. doi: 10.1016/j.eururo.2007.11.053. Epub 2007 Dec 7. Eur Urol. 2008. PMID: 18082932 No abstract available.
• The value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer.

  Gudjónsson S, Isfoss BL, Hansson K, Domanski AM, Warenholt J, Soller W, Lundberg LM, Liedberg F, Grabe M, Månsson W. Gudjónsson S, et al. Eur Urol. 2008 Aug;54(2):402-8. doi: 10.1016/j.eururo.2007.11.051. Epub 2007 Dec 7. Eur Urol. 2008. PMID: 18082934
• The predictive value of multi-targeted fluorescent in-situ hybridization in patients with history of bladder cancer.

  Gofrit ON, Zorn KC, Silvestre J, Shalhav AL, Zagaja GP, Msezane LP, Steinberg GD. Gofrit ON, et al. Urol Oncol. 2008 May-Jun;26(3):246-9. doi: 10.1016/j.urolonc.2007.02.011. Epub 2008 Feb 20. Urol Oncol. 2008. PMID: 18452813
• Bladder cancer detection using FISH (UroVysion assay).

  Halling KC, Kipp BR. Halling KC, et al. Adv Anat Pathol. 2008 Sep;15(5):279-86. doi: 10.1097/PAP.0b013e3181832320. Adv Anat Pathol. 2008. PMID: 18724101 Review.
• The economic benefit of photodynamic diagnosis in non-muscle invasive bladder cancer.

  Dindyal S, Nitkunan T, Bunce CJ. Dindyal S, et al. Photodiagnosis Photodyn Ther. 2008 Jun;5(2):153-8. doi: 10.1016/j.pdpdt.2008.05.001. Epub 2008 Jul 7. Photodiagnosis Photodyn Ther. 2008. PMID: 19356647 Review.